Delivery Order SPE2DB22D9239-SPE2DB25FDM04
Award Date 9/19/25
Potential Completion Date 9/22/25
Potential Value $33K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $16,434.34 to DMS Pharmaceutical Group Inc. for the supply of Cabometyx 60 mg tablets (30-count units) on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order represents a direct procurement with no set-aside designation. The award reflects performance under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA under the SPE2DB program, a $499.9 billion...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $32,966.42 to DMS Pharmaceutical Group Inc. for the supply of Cabometyx 40 mg tablets (30-count units) on September 17, 2025, with completion targeted for September 18, 2025. This firm fixed-price delivery order, issued without a set-aside designation, leverages DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, a $500 million vehicle valid through November 2026 that...
- The U.S. Defense Logistics Agency awarded a delivery order valued at $16,483.21 to DMS Pharmaceutical Group Inc. for the supply of Cabometyx 40 mg tablets (30-count units). This award, issued on August 19, 2025, represents a firm fixed-price delivery order with an ultimate completion date of August 20, 2025, and will be performed at the contractor's facility in Park Ridge, Illinois. The contract utilizes no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order award from the Defense Logistics Agency (DLA) on August 25, 2025, for Cabometyx 40 mg tablets (30-count units). This firm fixed-price delivery order, valued at approximately $33k, represents a single purchase action issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $500M vehicle valid...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $16,483.21 to DMS Pharmaceutical Group Inc. for the supply of Cabometyx 40 mg tablets (30-count units). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order is scheduled for completion by August 20, 2025, and represents performance at the contractor's Park Ridge facility. This delivery...
- The Defense Logistics Agency (DLA) Medical Supply Chain, through its Indefinite Delivery Contract (IDC) SPE2DB program with DMS Pharmaceutical Group Inc., awarded a firm fixed-price delivery order on August 14, 2025, for Cabometyx 40 mg tablets in quantities of 30. This delivery order, valued at approximately $65,933, represents a continuation of the agency's pharmaceutical supply chain operations supporting Department of Defense healthcare facilities. The award carries no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $32,868.70 to DMS Pharmaceutical Group Inc. for the supply of Cabometyx 60 mg tablets (30-count units). This firm fixed-price delivery order, issued on September 19, 2025, represents fulfillment under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at $499,999,999 and extending through November 2026. The delivery is scheduled for completion by...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $33,265.08 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Cabometyx 20 mg tablets (30-count units). This firm fixed-price delivery order, issued on August 27, 2025, with an ultimate completion date of August 28, 2025, represents a direct pharmaceutical supply fulfillment under DLA's pharmaceutical distribution operations. DMS...
- The Defense Logistics Agency awarded a delivery order valued at $32,966.42 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Cabometyx 40 mg tablets (30-count units). This firm fixed-price delivery order, issued on August 15, 2025, with an ultimate completion date of August 18, 2025, represents a discrete purchase under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $16,434.34 by the Defense Logistics Agency (DLA) on September 18, 2025, for the supply of Cabometyx 60 mg tablets (30-count packaging). This firm fixed-price delivery order, which has an ultimate completion date of September 19, 2025, represents a single pharmaceutical product delivery under the company's existing indefinite delivery contract...